Yoshito Arisawa
- Anatomy top 2%
- Surgery top 5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Abdominal vascular conditions and treatments 2
- Physiology top 10%
-
- Gastric Cancer Management and Outcomes 4
- Gallbladder and Bile Duct Disorders 3
- Metastasis and carcinoma case studies 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
-
- Gastrointestinal Tumor Research and Treatment 3
-
- Cancer Research and Treatments 2
Yoshito Arisawa
23 papers receiving 595 citations
Peers
Comparison fields: 5 of 51
- Anesthesiology and Pain Medicine 115
- Anatomy 19
- Endocrinology, Diabetes and Metabolism 221
- Surgery 539
- Physiology 192
Countries citing papers authored by Yoshito Arisawa
This map shows the geographic impact of Yoshito Arisawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshito Arisawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshito Arisawa more than expected).
Fields of papers citing papers by Yoshito Arisawa
This network shows the impact of papers produced by Yoshito Arisawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshito Arisawa. The network helps show where Yoshito Arisawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshito Arisawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 1 | |
| 2 | 2010 | 0 | |
| 3 | 2003 | 1 | |
| 4 | [Surgery using master-slave manipulators and telementoring]. | 2000 | 7 |
| 5 | 2000 | 119 | |
| 6 | 1999 | 0 | |
| 7 | [Adjuvant chemotherapy with cyclophosphamide, adriamycin, and CDDP (CAP) for high risk endometrial cancer after complete surgery]. | 1996 | 2 |
| 8 | 1996 | 4 | |
| 9 | 1995 | 15 | |
| 10 | 1995 | 2 | |
| 11 | [Analysis of familial aggregation of ovarian and breast cancer in patients with ovarian cancer]. | 1995 | 1 |
| 12 | 1994 | 4 | |
| 13 | 1992 | 2 | |
| 14 | [Studies on the efficacy and safety of panipenem/betamipron in infections in surgical domain and the safety when mixed with lactate containing infusion]. | 1992 | 2 |
| 15 | 1992 | 2 | |
| 16 | 1991 | 1 | |
| 17 | 1991 | 31 | |
| 18 | 1990 | 5 | |
| 19 | 1989 | 4 | |
| 20 | 1989 | 6 |
About Yoshito Arisawa
Yoshito Arisawa is a scholar working on Gastroenterology, Hepatology and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 623 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer Research and Treatments (2 papers), Metastasis and carcinoma case studies (2 papers) and Abdominal vascular conditions and treatments (2 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (115 citations), Anatomy (19 citations) and Endocrinology, Diabetes and Metabolism (221 citations). Yoshito Arisawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Katsuhiko Noga, Seiichiro Ishii, Toshiharu Furukawa, Masaki Kitajima, Masahiro Ohgami, Erika Sutanto‐Ward, Elin R. Sigurdson, Susumu Kodaira, Akihiko Suto and Tetsuro Kubota.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.